Skip to main content

Table 1 Baseline characteristics of 140 critically ill patients randomly assigned to the EMS group or the control group (mean ± standard deviation)

From: Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial

  EMS group
(n = 68)
Control group
(n = 72)
Age, years 61 ± 19 58 ± 18
Gender M/F 46/22 49/23
Severity of illness at ICU admission   
APACHE II score 18 ± 4 18 ± 5
SOFA score 9 ± 3 9 ± 3
SAPS III score 61 ± 13 60 ± 14
Diagnostic category at admission   
Sepsis/septic shock, n(%) 11 (16.2) 14 (19.4)
Trauma, n(%) 12 (17.6) 14 (19.4)
Post-surgical, n(%) 13 (19.1) 12 (16.7)
Brain injury, n(%) 24 (25.3) 23 (31.9)
Respiratory failure, n(%) 2 (2.9) 4 (5.6)
Other, n(%) 6 (8.8) 5 (6.9)
Comorbidities   
Cardiovascular, n(%) 31 (46) 34 (47)
Respiratory disease, n(%) 8 (12) 14 (19)
GI disease, n(%) 3 (4) 2 (3)
Hepatic disease, n(%) 3 (4) 1 (1)
Renal disease, n(%) 7 (10) 9 (13)
Diabetes melitus, n(%) 9 (13) 10 (14)
Hematological disease, n(%) 3 (4) 1 (1)
Other, n(%) 8 (12) 4 (6)
None reported, n(%) 17 (25) 23 (31)
Duration of sedation, days 12 ± 10 12 ± 11
Sepsis/septic shock, n(%) 54 (77) 58 (80)
Aminoglycoside use, days 5 ± 8 8 ± 11
Corticosteroids use, days 6 ± 9 5 ± 8
Neuromuscular blocking agents use, days 1 ± 2 3 ± 5
  1. No statistical significant difference is noted between the groups in any of the parameters.
  2. APACHE, Acute Physiology and Chronic Health Evaluation; EMS, electrical muscle stimulation; F, female; GI, gastrointestinal; M, male; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment.